Cargando…

Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models

The study aimed to investigate the causative species, antifungal susceptibility, and factors associated with oropharyngeal candidiasis (OPC) among Egyptian COVID-19 patients. This is an observational, case-controlled, single-center study that included three groups: COVID-19 patients (30), COVID-19 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Mahmoud A. F., El-Ansary, Mahmoud R. M., Bassyouni, Rasha H., Mahmoud, Eman E., Ali, Inas A., Ahmed, Tarek I., Hassan, Essam A., Samir, Tamer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316654/
https://www.ncbi.nlm.nih.gov/pubmed/35885623
http://dx.doi.org/10.3390/diagnostics12071719
_version_ 1784754868325449728
author Khalil, Mahmoud A. F.
El-Ansary, Mahmoud R. M.
Bassyouni, Rasha H.
Mahmoud, Eman E.
Ali, Inas A.
Ahmed, Tarek I.
Hassan, Essam A.
Samir, Tamer M.
author_facet Khalil, Mahmoud A. F.
El-Ansary, Mahmoud R. M.
Bassyouni, Rasha H.
Mahmoud, Eman E.
Ali, Inas A.
Ahmed, Tarek I.
Hassan, Essam A.
Samir, Tamer M.
author_sort Khalil, Mahmoud A. F.
collection PubMed
description The study aimed to investigate the causative species, antifungal susceptibility, and factors associated with oropharyngeal candidiasis (OPC) among Egyptian COVID-19 patients. This is an observational, case-controlled, single-center study that included three groups: COVID-19 patients (30), COVID-19 patients with OPC (39), and healthy individuals (31). Patients’ demographic data (age, sex), laboratory tests, comorbidities, treatment, and outcomes were included. Candida species were isolated from COVID-OPC patient’s oropharyngeal swabs by convenient microbiological methods. Isolated strains were tested for antimicrobial susceptibility, biofilm production, aspartyl protease, and phospholipase activities. The most common respiratory symptoms reported were dyspnea (36/39; 92.4%) and cough (33/39; 84.7%). Candida albicans was the most common isolated species, accounting for 74.36% (29/39), followed by Candida tropicalis and Candida glabrata (15.38% and 10.26%, respectively). Amphotericin was effective against all isolates, while fluconazole was effective against 61.5%. A total of 53.8% of the isolates were biofilm producers. The phospholipase activity of C. albicans was detected among 58.6% (17/29) of the isolates. Significant variables from this study were used to create two equations from a regression model that can predict the severity of disease course and liability to fungal infection, with a stativity of 87% and 91%, respectively. According to our findings, COVID-19 patients with moderate to severe infection under prolonged use of broad-spectrum antibiotics and corticosteroids should be considered a high-risk group for developing OPC, and prophylactic measures are recommended to be included in the treatment protocols. In addition, due to the increased rate of fluconazole resistance, other new antifungals should be considered.
format Online
Article
Text
id pubmed-9316654
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93166542022-07-27 Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models Khalil, Mahmoud A. F. El-Ansary, Mahmoud R. M. Bassyouni, Rasha H. Mahmoud, Eman E. Ali, Inas A. Ahmed, Tarek I. Hassan, Essam A. Samir, Tamer M. Diagnostics (Basel) Article The study aimed to investigate the causative species, antifungal susceptibility, and factors associated with oropharyngeal candidiasis (OPC) among Egyptian COVID-19 patients. This is an observational, case-controlled, single-center study that included three groups: COVID-19 patients (30), COVID-19 patients with OPC (39), and healthy individuals (31). Patients’ demographic data (age, sex), laboratory tests, comorbidities, treatment, and outcomes were included. Candida species were isolated from COVID-OPC patient’s oropharyngeal swabs by convenient microbiological methods. Isolated strains were tested for antimicrobial susceptibility, biofilm production, aspartyl protease, and phospholipase activities. The most common respiratory symptoms reported were dyspnea (36/39; 92.4%) and cough (33/39; 84.7%). Candida albicans was the most common isolated species, accounting for 74.36% (29/39), followed by Candida tropicalis and Candida glabrata (15.38% and 10.26%, respectively). Amphotericin was effective against all isolates, while fluconazole was effective against 61.5%. A total of 53.8% of the isolates were biofilm producers. The phospholipase activity of C. albicans was detected among 58.6% (17/29) of the isolates. Significant variables from this study were used to create two equations from a regression model that can predict the severity of disease course and liability to fungal infection, with a stativity of 87% and 91%, respectively. According to our findings, COVID-19 patients with moderate to severe infection under prolonged use of broad-spectrum antibiotics and corticosteroids should be considered a high-risk group for developing OPC, and prophylactic measures are recommended to be included in the treatment protocols. In addition, due to the increased rate of fluconazole resistance, other new antifungals should be considered. MDPI 2022-07-15 /pmc/articles/PMC9316654/ /pubmed/35885623 http://dx.doi.org/10.3390/diagnostics12071719 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khalil, Mahmoud A. F.
El-Ansary, Mahmoud R. M.
Bassyouni, Rasha H.
Mahmoud, Eman E.
Ali, Inas A.
Ahmed, Tarek I.
Hassan, Essam A.
Samir, Tamer M.
Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
title Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
title_full Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
title_fullStr Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
title_full_unstemmed Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
title_short Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
title_sort oropharyngeal candidiasis among egyptian covid-19 patients: clinical characteristics, species identification, and antifungal susceptibility, with disease severity and fungal coinfection prediction models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316654/
https://www.ncbi.nlm.nih.gov/pubmed/35885623
http://dx.doi.org/10.3390/diagnostics12071719
work_keys_str_mv AT khalilmahmoudaf oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT elansarymahmoudrm oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT bassyounirashah oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT mahmoudemane oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT aliinasa oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT ahmedtareki oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT hassanessama oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels
AT samirtamerm oropharyngealcandidiasisamongegyptiancovid19patientsclinicalcharacteristicsspeciesidentificationandantifungalsusceptibilitywithdiseaseseverityandfungalcoinfectionpredictionmodels